|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-1-29
|
|
pubmed:abstractText |
CEBPA mutations are found as either biallelic (biCEBPA) or monoallelic (moCEBPA). We set out to explore whether the kind of CEBPA mutation is of prognostic relevance in cytogenetically normal (CN) acute myeloid leukemia (AML).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CCAAT-Enhancer-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/CEBPA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/FLT3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/MLL protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Myeloid-Lymphoid Leukemia Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/fms-Like Tyrosine Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/nucleophosmin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BüchnerThomasT,
pubmed-author:BenthausTobiasT,
pubmed-author:BerdelWolfgang EWE,
pubmed-author:BohlanderStefan KSK,
pubmed-author:BraessJanJ,
pubmed-author:DufourAnnikaA,
pubmed-author:HiddemannWolfgangW,
pubmed-author:HosterEvaE,
pubmed-author:MetzelerKlaus HKH,
pubmed-author:SauerlandMaria-CristinaMC,
pubmed-author:SchneiderFriederikeF,
pubmed-author:SchneiderStephanieS,
pubmed-author:SpiekermannKarstenK,
pubmed-author:WörmannBernhardB,
pubmed-author:ZellmeierEvelynE
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
570-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20038735-Adolescent,
pubmed-meshheading:20038735-Adult,
pubmed-meshheading:20038735-Aged,
pubmed-meshheading:20038735-Aged, 80 and over,
pubmed-meshheading:20038735-Alleles,
pubmed-meshheading:20038735-CCAAT-Enhancer-Binding Proteins,
pubmed-meshheading:20038735-Female,
pubmed-meshheading:20038735-Gene Expression Profiling,
pubmed-meshheading:20038735-Gene Expression Regulation, Leukemic,
pubmed-meshheading:20038735-Humans,
pubmed-meshheading:20038735-Karyotyping,
pubmed-meshheading:20038735-Leukemia, Myeloid, Acute,
pubmed-meshheading:20038735-Male,
pubmed-meshheading:20038735-Middle Aged,
pubmed-meshheading:20038735-Mutation,
pubmed-meshheading:20038735-Myeloid-Lymphoid Leukemia Protein,
pubmed-meshheading:20038735-Neoplasm Staging,
pubmed-meshheading:20038735-Nuclear Proteins,
pubmed-meshheading:20038735-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:20038735-Prognosis,
pubmed-meshheading:20038735-Survival Rate,
pubmed-meshheading:20038735-Treatment Outcome,
pubmed-meshheading:20038735-Tumor Markers, Biological,
pubmed-meshheading:20038735-Young Adult,
pubmed-meshheading:20038735-fms-Like Tyrosine Kinase 3
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.
|
|
pubmed:affiliation |
Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University of Munich-Grosshadern, München, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
